Title:
TABLET HAVING FEXOFENADINE AS EFFECTIVE COMPONENT THEREOF
Document Type and Number:
WIPO Patent Application WO/2017/073738
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a smaller fexofenadine tablet. The present invention provides a fexofenadine tablet that is smaller and has a high fexofenadine content, fexofenadine being the effective component thereof, as a result of using carmellose calcium as a disintegrating agent. This fexofenadine tablet is highly useful for allergy treatment and prevention, as a result of being small and therefore easy to ingest and as a result of having an appropriate elution speed.
Inventors:
ISHIBASHI NOBUYUKI (JP)
Application Number:
PCT/JP2016/082091
Publication Date:
May 04, 2017
Filing Date:
October 28, 2016
Export Citation:
Assignee:
NIPPON ZOKI PHARMACEUTICAL CO (JP)
International Classes:
A61K31/445; A61K9/20; A61K9/28; A61K47/38; A61P37/08
Domestic Patent References:
| WO2014096387A1 | 2014-06-26 | |||
| WO2013081044A1 | 2013-06-06 |
Foreign References:
| JP2015044774A | 2015-03-12 | |||
| JP2010132616A | 2010-06-17 | |||
| JP2007056011A | 2007-03-08 |
Other References:
"Allergy-sei Shikkan Chiryozai Japanese Pharmacopoeia Fexofenadine Hydrochloride Tablets 30mg 'TOWA' Fexofenadine Hydrochloride Tablets 60mg 'TOWA' Tenpu Bunsho", PHARMACEUTICALS AND MEDICAL DEVICES AGENCY, 4 October 2013 (2013-10-04), XP055598400, Retrieved from the Internet [retrieved on 20170117]
Attorney, Agent or Firm:
FUJII, Ikuro (JP)
Download PDF: